SEARCH

SEARCH BY CITATION

References

  • Ahmed, A. & Keeffe, E.B. (1999) Lamivudine therapy in chemotherapy-induced reactivation of hepatitis B virus infection. American Journal of Gastroenterology, 94, 249251.
    Direct Link:
  • Al-Taie, O.H., Mork, H., Gassel, A.M., Wilhelm, M., Weissbrich, B. & Scheurlen, M. (1999) Prevention of hepatitis B flare-up during chemotherapy using lamivudine: case report and review of the literature. Annals of Hematology, 78, 247249.
  • Avettand-Fenoel, V., Thabut, D., Katlama, C., Poynard, T. & Thibault, V. (2006) Immune suppression as the etiology of failure to detect anti-HBc antibodies in patients with chronic hepatitis B virus infection. Journal of Clinical Microbiology, 44, 22502253.
  • Banatvala, J., Van, Damme, P. & Emiroglu, N. (2006) Hepatitis B immunisation in Britain: time to change? British Medical Journal 332, 804805.
  • Bertoletti, A. & Gehring, A.J. (2006) The immune response during hepatitis B virus infection. Journal of General Virology, 87, 14391449.
  • Bonkovsky, H.L., Jones, B.P., LaBrecque, D.R. & Shedlofsky, S.I. (2006) Drug induced liver injury. In: Zakim and Boyer's Hepatology (ed. by T.D.Boyer, T.L.Wright & M.P.Mann), pp. 503550. Elsevier, Saunders.
  • Ter Borg, F., Smorenburg, S., De Man, R.A., Rietbroek, R.C., Chamuleau, R.A.F.M. & Jones, E.A. (1998) Recovery from life-threatening corticosteroid-unresponsive, chemotherapy-related reactivation of hepatitis B associated with lamivudine therapy. Digestive Disease Science, 43, 22672270.
  • Calabrese L.H., Zein N.N. & Vassilopoulos D. (2006) Hepatitis B virus reactivation with immunosuppressive therapy in rheumatic diseases:assessment and preventive strategies. Annals of Rheumatic Diseases, 65, 983989.
  • Chang, T.T., Gish, R.G., De Man, R., Gadano, A., Sollano, J., Chao, Y.C., Lok, A.S., Han, K.H., Goodman, Z., Zhu, J., Cross, A., DeHertogh, D., Wilber, R., Colonno, R. & Apelian, D. (2006) A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B. BEHoLD AI463022 Study Group. New England Journal of Medicine, 354, 10011010.
  • Chen, P.M., Fan, S., Liu, C.J., Hsieh, R.K., Liu, J.H., Chuang, M.W., Liu, R.S. & Tzeng, C.H. (1990) Changing of hepatitis B virus markers in patients with bone marrow transplantation. Transplantation, 49, 708713.
  • Chen, P.M., Fan, S., Liu, J.H., Chiou, T.J., Hsieh, S.R., Liu, R.S. & Tzeng C.H. (1993) Reactivation of hepatitis B virus in two chronic GVHD patients after transplant. International Journal of Hematology, 58, 183188.
  • Cheng, A.L., Hsiung, C.A., Su, I.J., Chen, P.J., Chang, M.C., Tsao, C.J., Kau, W.Y., Uen, W.C., Hsu, C.H., Tien, H.F., Chen, L.T. & Whang-Peng, J. (2003) Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma. Hepatology, 37, 13201328.
  • Chisari, F.V. (1997) Cytotoxic T cells and viral hepatitis. Journal of Clinical Investigation, 99, 14721477.
  • Clark, F.L., Drummond, M.W., Chambers, S., Chapman, B.A. & PaHon, W.N. (1998) Successful treatment with lamivudine for fulminant reactivated hepatitis B infection following intensive therapy for high-grade Hodgkin's lymphoma. Annals of Oncology, 9, 385387.
  • Cortelezzi, A., Vigano, M., Zilioli, V.R., Fantini, N.N., Pasquini, M.C., Deliliers, G.L., Colombo, M. & Lampertico P. (2006) Adefovir added to lamivudine for hepatitis B recurrent infection in refractory B-cell chronic lymphocytic leukemia on prolonged therapy with Campath-1H. Journal of Clinical Virology, 35, 467469.
  • Dahmen, U., Dirsch, O., Li, J., Fiedle, M., Lu, M., Rispeter, K., Picucci, M., Broelsch, C.F. & Roggendorg, M. (2004) Adoptive transfer of immunity: a new strategy to interfere with severe hepatitis virus re-infection after woodchuck liver transplantation. Transplantation, 77, 965972.
  • Dai, M.S., Chao, T.Y., Kao, W.Y., Shyu, R.Y. & Liu, T.M. (2004) Delayed hepatitis B reactivation after cessation of preemptive lamivudine in lymphoma patients treated with rituximab plus CHOP. Annals of Hematology, 83, 769774.
  • Dhedin, N., Douvin, C., Kuentz, M., Saint Marc, M.F., Reman, O., Rieux, C., Bernandi, F., Novol, F., Cordonnier, C., Bobin, D., Metreau, J.M. & Vernaut, J.P. (1998) Reverse seroconversion of hepatitis B after allogeneic bone marrow transplantation: a retrospective study of 37 patients with pre-transplant anti-HBs and anti-HBc. Transplantation, 66, 616619.
  • Fouillard, L., Serfaty, L. & Gozlan, J. (2006) Adefovir therapy for lamivudine escape and hepatitis B virus reactivation after reduced intensity conditioning allogeneic stem cell transplantation. Bone Marrow Transplantation, 37, 625626.
  • Gish R.G. & Locarnini S.A. (2006) Chronic heapatitis B: current testing strategies. Clinical Gastroenterology and Hepatology, 4, 666676
  • Goyama, S., Kanda, Y., Nannya, Y., Kawazu, M., Takeshita, M., Niino, M., Komeno, Y., Nakamoto, T., Kurokawa, M., Tsujino, S., Ogawa, S., Aoki, K., Chiba, S., Motokura, T., Shiratory, Y. & Hirai, H. (2002) Reverse seroconversion of hepatitis B virus after hematopoietic stem cell transplantation. Leukemia and Lymphoma, 43, 21592163.
  • Hsiao, L.T., Chiou, T.F., Liu, F.H., Chu, C.J., Lin, Y.C., Chao, T.C., Wang, W.S., Yen, C.C., Yang, M.H., Tzeng, C.H. & Chen, P.M. (2006) Extended lamivudine therapy against hepatitis B virus infection in hematopoietic stem cell transplant recipients. Biology of Blood Marrow Transplantation, 12, 8494.
  • Hsu, C.H., Hsu, H.C., Chen, H.L., Gao, M., Yeh, P.Y., Chen, P.J & Cheng, A.L. (2004) Doxorubicin activates hepatitis B virus (HBV) replication in HBV-harboring hepatoblastoma cells. A possible novel mechanism of HBV reactivation in HBV carriers receiving systemic chemotherapy. Anticancer Research, 24, 30353040.
  • Hui, C.K., Cheung, W.W., Au, W.Y., Lie, A.K., Zhang, H.Y., Yueng, Y.H., Wong, B.C., Leung, N., Kwong, Y.L., Liang, R. & Lau, G.K. (2005a) Hepatitis B reactivation after withdrawal of pre-emptive lamivudine in patients with haematological malignancy on completion of cytotoxic chemotherapy. Gut, 54, 15971603.
  • Hui, C.K., Bowden, S., Jackson, K., Au, W.Y., Fong, D.Y., Lie, A.K., Chim, C.S., Liang, R. & Lau, G.K. (2005b) Clinical significance of intrahepatic hepatitis B virus covalently closed circular DNA in chronic hepatitis B patients who received cytotoxic chemotherapy. Blood, 105, 26162617.
  • Hui, C.K., Cheung, W.W.W., Zhang, H.Y., Au, W.Y., Yueng, Y.H., Leung, A.Y.H., Leung, N., Luk, J.M., Lie, A.K.W., Kwong, Y.L., Liang, R. & Lau, G.K.K. (2006) Kinetics and risk of de novo hepatitis B infection in HBsAg negative patients undergoing chemotherapy. Gastroenterology, 131, 5968.
  • Iannitto, E., Minardi, V., Calvaruso, G., Mule, A., Ammatuna, E., Di Trapani, R., Ferraro, D., Abbadessa, V., Craxi, A. & Di Stefano, R. (2005) Hepatitis B virus reactivation and alemtuzumab therapy. European Journal of Haematology, 74, 254258.
  • Idilman R. (2006) Duration of lamivudine prophylaxis in inactive hepatitis B virus carriers with haemato oncological malignancies whon receive chemotherapy. Gut (letter), 55, 12081209.
  • Idilman, R., Arat, M., Soydan, E., Toruner, M., Soykan, I., Akbulut, H., Arslan, O., Ozcan, M., Turkyilmaz, A.R., Bozdayi, M., Karayalcin, S., Van Thiel, D.H., Ozden, A., Beksac, M. & Akan, H. (2004) Lamivudine prophylaxis for prevention of chemotherapy-induced hepatitis B virus reactivation in hepatitis B virus carriers with malignancies. Journal of Viral Hepatology, 11, 141147.
  • Ilan, Y., Nagler, A., Adler, R., Naparstek, E., Or, R., Slavin, S., Brautbar, C. & Shouval, D. (1993a) Adoptive transfer of immunity to hepatitis B virus after T cell-depleted allogeneic bone marrow transplantation. Hepatology, 18, 246252.
  • Ilan, Y., Nagler, A., Adler, R., Tur-Kaspa, R., Slavin, S. & Shouval, D. (1993b) Ablation of persistent hepatitis B by bone marrow transplantation from an hepatitis B immune donor: a case report. Gastroenterology, 104, 18181821.
  • Ilan, Y., Nagler, A., Zeira, E., Adler, R., Slavin, S. & Shouval D. (2000) Maintenance of immune memory to hepatitis B envelope protein following adoptive transfer of immunity in bone marrow transplant recipients. Bone Marrow Transplantation, 26, 633638.
  • Iwai, K., Tashima, M., Itoh, M., Okazaki, T., Yamamoto, K., Ohno, H., Marusawa, H., Ueda, K., Nakamura, T., Chiba, T. & Uchiyama, T. (2000) Fulminant hepatitis B following bone marrow transplantation in an HBsAg-negative, HBsAb-positive recipient; reactivation of dormant virus during the immunosuppressive period. Bone Marrow Transplantation, 25, 105108.
  • Jazayeri, M.S., Basuni, A.A., Cooksley, G., Locarnini, S. & Carman, W.F. (2004) Hepatitis B virus genotypes core gene variability and ethnicity in the pacific region. Journal of Hepatology, 41, 139146.
  • Kao, J.H., Chen, P.J. & Lai, M.Y. (2000) Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B. Gastroenterology, 118, 554559.
  • Knöll, A., Boehm, S., Hahn, J., Holler, E. & Jilg, W. (2004) Reactivation of resolved hepatitis B virus infection after allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplantation, 33, 925929.
  • Van Der Kolk, L.E., Baars, J.W., Prins, M.H. & Van Oers, M.H. (2002) Rituximab treatment results in impaired secondary humoral immune responsiveness. Blood, 100, 22572259.
  • Kumagai, K., Takagi, T., Nakamura, S., Sawada, U., Kura, U., Kodama, F., Shimano, S., Kudoh, I., Nakamura, H., Sawada, K. & Ohnoshi, T. (1997) Hepatitis B virus carriers in the treatment of malignant lymphomas: an epidemiological study in Japan. Annals of Oncology, 8 (Suppl. 1), 107109.
  • Lai, C.L., Shouval, D., Lok, A.S., Chang, T.T., Cheinquer, H., Goodman, Z., DeHertogh, D., Wilber, R., Zink, R.C., Cross, A., Colonno, R. & Fernandes, L. BEHoLD AI463027 Study Group, (2006) Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B. New England Journal of Medicine, 354, 10111020. Erratum in: New England Journal of Medicine, 2006, 354, 1863.
  • Lau, G.K.K., Lok, A.S., Liang, R.H., Lai, C.L., Chiu, E.K., Lau, Y.L. & Lam, S.K. (1997) Clearence of hepatitis B surface antigen after bone marrow transplantation: role of adoptive immune transfer. Hepatology, 25, 14971501.
  • Lau, G.K.K., Lee, C.K. & Liang, R. (1999) Hepatitis B virus infection and bone marrow transplantation. Clinical Reviews in Oncology and Hematology, 31, 7176.
  • Lau, G.K.K., Leung, Y.H., Fong, D.Y., Au, W.Y., Kwong, Y.L., Lie, A., Hou, J.L., Wen, Y.M., Nanji, A. & Liang, R. (2002a) High hepatitis B virus (HBV) DNA viral load as the most important risk factor for HBV reactivation in patients positive for HBV surface antigen undergoing autologous hematopoietic cell transplantation. Blood, 99, 23242330.
  • Lau, G.K.K., Suri, D., Liang, R., Rigopoulou, E., Thomas, M.G., Mullerova, I., Nanji, A., Yuen, S.T., Williams, R. & Naoumov, N.V. (2002b) Resolution of chronic hepatitis B and anti-HBs seroconversion in humans by adoptive transfer of immunity to hepatitis B core antigen. Gastroenterology, 122, 614624.
  • Lau, G.K.K., Yiu, H.H., Fong, D.Y., Cheng, H.C., Au, W.Y., Lai, L.S., Cheung, M., Zhang, H.Y., Lie, A., Ngan, R. & Liang, R. (2003) Early is superior to deferred preemptive lamivudine therapy for hepatitis B patients undergoing chemotherapy. Gastroenterology, 125, 17421749.
  • Lavanchy, D. (2004) Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. Journal of Viral Hepatology, 11, 97107.
  • Law, J.K., Ho, J.K., Hoskins, P.J., Erb, S.R., Steinbrecher, U.P. & Yoshida, E.M. (2005) Fatal reactivation of hepatitis B post-chemotherapy for lymphoma in a hepatitis B surface antigen-negative, hepatitis B core antibody-positive patient: potential implications for future prophylaxis recommendations. Leukemia and Lymphoma, 46, 10851089.
  • Leaw, S.J., Yen, C.J., Huang, W.T., Chen, T.Y., Su, W.C. & TSao, C.J. (2004) Preemptive use of interferon or lamivudine for hepatitis B reactivation in patients with aggressive lymphoma receiving chemotherapy. Annals of Hematology, 83, 270275.
  • Lee, G.W., Ryu, M.H., Lee, J.L., Oh, S., Kim, E., Lee, J.H., Kim, S.B., Kim, S.W., Suh, C., Lee, K.H., Kim, W.K., Lee, J.S. & Kang, Y.K. (2003) The prophylactic use of lamivudine can maintain dose-intensity of adriamycin in hepatitis B surface antigen positive patients with non-Hodgkin's lymphoma who receive cytotoxic chemotherapy. Journal of Korean Medical Science, 18, 849854.
  • Li, J., Dahmen, U., Dirsch, O.R., Gu, Y., Polywka, S. & Broelsch, C.E. (2002) The potential role of BMT in augmenting donor derived immunity to hepatitis B after rat liver transplantation. Liver Translantation, 8, 397404.
  • Li, Y.H., He, Y.F., Jiang, W.Q., Wang, F.H., Lin, X.B., Zhang, L., Xia, Z.J., Sun, X.F., Huang, H.Q., Lin, T.Y., He, Y.J. & Guan, Z.Z. (2006) Lamivudine prophylaxis reduces the incidence and severity of hepatitis in hepatitis B virus carriers who receive chemotherapy for lymphoma. Cancer, 106, 13201325.
  • Liang, R.H., Lok, A.S., Lai C.L., Chan, T.K., Todd, D. & Chiu, E.K. (1990) HepatitisB infection in patients with lymphomas. Hematology and Oncology, 8, 261270.
  • Liang, R., Lau, G.K.K & Kwong, Y.L. (1999) Chemotherapy and bone marrow transplantation for cancer patients who are also chronic hepatitis B carriers: a review of the problem. Journal of Clinical Oncology, 17, 394398.
  • Liao, C.A., Lee, C.M., Wu, H.C., Wang, M.C., Lu, S.N. & Eng, S.L. (2002) Lamivudine for the treatment of hepatitis B virus reactivation following chemotherapy for non-Hodgkin's lymphoma. British Journal of Haematology, 116, 166169.
  • Liaw, Y.F. (1998) Hepatitis viruses under immunosuppressive agents. Journal of Gastroenterology and Hepatology, 13, 1420.
  • Lim, L.L., Wai, C.T., Lee Y.M., Kong, H.L., Lim, R., Kaoy, F. & Lim, G. (2002) Prophylactic lamivudine prevents hepatitis B reactivation in chemotherapy patients. Alimentary Pharmacology and therapeutics, 16, 19391944.
  • Lindemann, M., Barsegian, V., Runde, V., Fiedler, M., Heerman, K.H., Schaefer, U.W., Roggendorf, M. & Grosse-Wilde, H. (2003) Transfer of humoral and cellular hepatitis B immunity by allogeneic hematopoietic cell transplantation. Transplantation, 75, 833838.
  • Locarnini, S. (2004) Molecular virology of hepatitis B virus. Seminars in Liver Diseases, 24 (Suppl. 1), 310.
  • Lok, AS. & Lai, C.L. (1989) Alpha-fetoprotein monitoring in Chinese patients with chronic hepatitis B virus infection: role in the early detection of hepatocellular carcinoma. Hepatology, 9, 110115.
  • Lok, A.S. & Lai, C.L. (1990) Acute exacerbations in Chinese patients with chronic hepatitis B virus (HBV) infection. Incidence, predisposing factors and etiology. Journal of Hepatology, 10, 2934.
  • Lok, AS., Lai, C.L., Wu, P.C., Leung, E.K. & Lam, T.S. (1987) Spontaneous hepatitis B e antigen to antibody seroconversion and reversion in Chinese patients with chronic hepatitis B virus infection. Gastroenterology, 92, 18391843.
  • Lok, A.S., Liang, R.H., Chiu, E.K., Wong, K.L., Chan, T.K. & Todd, D. (1991) Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study. Gastroenterology, 100, 182188.
  • Lok, A.S., Wu, P.C., Lai, C.L., Lau, J.Y., Leung, E.K., Wong, L.S., Ma, O.C., Lauder, I.J., Ng, C.P. & Chung, H.T. (1992) A controlled trial of interferon with or without prednisone priming for hepatitis B. Gastroenterology, 102, 20912097.
  • Markovic, S., Drozina, G., Vovk, M. & Fidler-Jenko, M. (1999) Reactivation of hepatitis B but not hepatitis C in patients with malignant lymphoma and immunosuppressive therapy. A prospective study in 305 patients. Hepato-Gastroenterology, 46, 29252930.
  • Martin, B.A., Rowe, J.M., Kouides, P.A. & DiPersio, J.F. (1995) Hepatitis B reactivation following allogeneic bone marrow transplantation: case report and review of the literature. Bone Marrow Transplantation, 15, 145148.
  • Mason, A.L., Xu, L., Guo, L., Kuhns, M. & Perrillo, R.P. (1998) Molecular basis for persistent hepatitis B infection in the liver after clearance of serum hepatitis B surface antigen. Hepatology, 27, 17361742.
  • McMahon, B.J. (2005) Epidemiology and natural history of hepatitis B. Seminars in Liver Diseases, 25 (Suppl. 1), 38.
  • Nakamura, Y., Motokura, T., Fujita, A., Yamashita, T. & Ogata, E. (1996) Severe hepatitis related to chemotherapy in hepatitis B virus carriers with hematologic malignancies. Survery in Japapn, 1987–1991. Cancer, 78, 22102215.
  • Niscola, P., Del Principe, M.I., Maurillo, L., Venditti, A., Buccisano, F., Piccioni, D., Amadori, S. & Del Poeta, G. (2005) Fulminant B hepatitis in a surface antigen-negative patient with B-cell chronic lymphocytic leukaemia after rituximab therapy. Leukemia, 19, 18401841.
  • Nordbo, S.A., Skaug, K., Holter, E., Waage, A. & Brinch, L. (2000) Reactivation of hepatitis B virus infection in an anti-HBc and anti-HBs positive patient after allogeneic bone marrow transplantation. European Journal of Haematology, 65, 8687.
  • Nunez, M. & Soriano, R. (2005) Management of patients co-infected with hepatitis B and HIV. Lancet Infectious Diseases, 5, 374382.
  • Onozawa, M., Hashino, S., Izumiyama, K., Kahata, K., Chuma, M., Mori, A., Kondo, T., Toyoshima, N., Ota, S., Kobayashi, S., Hige, S., Toubai, T., Tanaka, J., Imamura, M. & Asaka, M. (2005) Progressive disappearance of anti-hepatitis B surface antigen antibody and reverse seroconversion after allogeneic hematopoietic stem cell transplantation in patients with previous hepatitis B virus infection. Transplantation, 79, 616619.
  • Osborn, M.K. & Lok, A.S. (2006) Antiviral options for the treatment of chronic hepatitis B. Journal of Antimicrobial Chemotherapy, 57, 10301034; epub 4 April 2006.
  • Osterburg, A., Dyer, M.J., Bunjes, D., Pangalis, G.A., Bastion, Y., Catoysky, D. & Mellstedt, H. (1997) Phase II multicenter study of human CD52 antibody in previously treated chronic lymphocytic leukemia. European Study Group of CAMPATH-1H treatment in chronic lymphocytic leukemia. Journal of Clinical Oncology, 15, 15671574.
  • Ozguroglu, M., Bilici, A., Turna, H. & Serdengecti, S. (2004) Reactivation of hepatitis B infection with cytotoxic therapy in non-Hodgkin lymphoma. Medical Oncology, 21, 6772.
  • Perrillo, R.P. (2001) Acute flares in chronic hepatitis B: the natural and unnatural history of an immunologically mediated liver disease. Gastroenterology, 120, 10091022.
  • Persico, M., De Marino, F, Russo, G.D., Morante, A., Rotoloi, B. & Torella, R., De Renzo, A. (2002) Efficay of lamivudine to prevent hepatitis reactivation in hepatitus B virus infected patients treated for non-Hodgkin lymphoma. Blood, 99, 724725.
  • Petrelli, E., Balducci, M., Pieretti, C., Rocchi, M.B., Clementi, M. & Manzin, A. (2001) Lamivudine treatment failure in preventing fatal outcome of de novo severe acute hepatitis B in patients with haematological diseases. Journal of Hepatology, 35, 823826.
  • Picardi, M., Selleri, C., De Rosa, G., Raiola, A., Pezzullo, L. & Rotoli, B. (1998) Lamivudine treatment for chronic replicative hepatitis B virus infection after allogeneic bone marrow transplantation. Bone Marrow Transplantation, 21, 12671269.
  • Puoti, M., Torti, C., Bruno, R., Filice, G. & Carosi, G. (2006) Natural history of chronic hepatitis B in co-infected patients. Journal of Hepatology, 44 (Suppl. 1), S65S70; epub 28 November 2005.
  • Rossi, G., Pelizzari, A., Motta, M. & Puoti, M. (2001) Primary prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HBsAg carriers with lymphoid malignancies treated with chemotherapy. British Journal of Haematology, 115, 5862.
  • Sarrecchia, C., Cappelli, A. & Aiello, P. (2005) HBV reactivation with fatal fulminat hepatitis during rituximab treatment in a subject negative for HBsAg and positive for HBsAb and HBcAb. Journal of Infection and Chemotherapy, 11, 189191.
  • Seth, P., Alrajhi, A.A., Kagevi, I., Chaudhary, M.A., Colcol, E., Sahovic, E., Aljurf, M. & Gyger, M. (2002) Hepatitis B virus reactivation with clinical flare in allogeneic stem cell transplants with chronic graft-versus-host disease. Bone Marrow Transplantation, 30, 189194.
  • Shibolet, O., Ilan, Y., Gillis, S., Hubert, A., Shouval, D. & Safadi, R. (2002) Lamivudine therapy for prevention of immunosuppressive-induced hepatitis B virus reactivation in hepatitis B surface antigen carriers. Blood, 100, 391396.
  • Shouval, D. (2003) Hepatitis B vaccines. Journal of Hepatology, 39, S70-S76.
  • Shouval, D. (2007) Adoptive transfer of immunity to HBV in liver transplant patients: a step forward toward the proof of concept for therapeutic vaccination or a transient immunologic phenomenon? Liver Transplantation (Editorial, in press).
  • Shouval, D. & Ilan, Y. (1995) Transplantation of hepatitis B immune lymphocytes as means for adoptive transfer of immunity to hepatitis B virus. Journal of Hepatology 23, 98101.
  • Shouval, D., Adler, R. & Ilan, Y. (1993) Adoptive transfer of immunity to hepatitis B virus in mice by bone marrow transplantation from HBV immune donors. Hepatology, 17, 955959.
  • Simpson, N.D., Simpson, P.W., Ahmed, A.M., Nguyen, M.H., Garcia, G., Keeffe, E.B. & Ahmed, A. (2003) Prophylaxis against chemotherapy-induced reactivation of hepatitis B virus infection with Lamivudine. Journal of Clinical Gastroenterology, 37, 6871.
  • Strasser, S.I. & McDonald, G.B. (1999) Hepatitis viruses and hematopoietic cell transplantation: a guide to patient and donor management. Blood, 93, 11271136.
  • Takai, S., Tsurumi, H., Ando, K., Kasahara, S., Sawada, M., Yamada, T., Hara, T., Fukuno, K., Takahashi, T., Oyama, M., Onishi, H., Tomita, E., Takami, M., Imawari, M. & Moriwaki, H. (2005) Prevalence of hepatitis B and C virus infection in haematological malignancies and liver injury following chemotherapy. European Journal of Haematology, 74, 158165.
  • Tillman, H.L., Wedemeyer, H. & Manns, M.P. (2003) Treatment of hepatitis B in special patient groups: hemodialysis, heart and renal transplant, fulminant hepatitis, hepatitis B virus reactivation. Journal of Hepatology, 39 (Suppl. 1): 206211.
  • Tur-Kaspa, R., Burk, R.D., Shaul, Y. & Shafritz, D.A. (1986) Hepatitis B virus DNA contains a glucocorticoid-responsive element. Proceedings of the National Academy of Science, USA, 83, 16271631.
  • Vassiliadis, T., Garipidou, V., Tziomalos, K., Perifanis, V., Giouleme, O. & Vakalopoulou, S. (2005) Prevention of hepatitis B reactivation with lamivudine in hepatitis B virus carriers with hematologic malignancies treated with chemotherapy – a prospective case series. American Journal of Hematology, 80, 197203.
  • Vento, S, Cainelli, F & Longhi M.S. (2002) Reactivation of replication of hepatitis B and C viruses after immunosuppression therapy: an unresolved issue. Lancet Oncology, 3, 333340.
  • Wands, J.R., Chura, C.M., Roll, F.J. & Maddrey, W.C. (1975) Serial studies of hepatitis associated antigen and antibody in patients receiving antitumor chemotherapy for myeloproliferative and lymphoproliferative disorders. Gastroenterology, 68, 105112.
  • Webster, A., Brenner, M.K., Prentice, H.G. & Griffiths, P.D. (1989) Fatal hepatitis B reactivation after autologous bone marrow transplantation. Bone Marrow Transplantation, 4, 207208.
  • Westhoff, T.H., Jochimsen, F., Schmittel, A., Stoffler-Meilicke, M., Schafer, J.H., Zidek, W., Gerlich, W.H. & Thiel, E. (2003) Fatal hepatitis B virus eactivation by an escape mutant following rituximab therapy. Blood, 102, 1930.
  • Wong, S.N. & Lok, A.S. (2006) Update on viral hepatitis: 2005. Current Opinions in Gastroenterology, 22, 241247.
  • Xunrong, L, Yan, A.W., Liang, R & Lau, G.K.K. (2001) Hepatitis B reactivation after cytotoxic or immunosuppressive therapy-pathogenesis and management. Reviews in Medical Virology, 11, 287299
  • Yeo, W. & Johnson, P.J. (2006) Diagnosis prevention and management of hepatitis B virus reactivation during anticancer therapy. Hepatology, 43, 209220
  • Yeo, W., Steinberg, J.L., Tam, J.S., Chan, P.K., Leung, N.W., Lam, K.C., Mok, T.S. & Johnson, P.J. (1999) Lamivudine in the treatment of hepatitis B virus reactivation during cytotoxic chemotherapy. Journal Medical Virology, 59, 263269.
  • Yeo, W., Chan, P.K.S., Zhong, S., Ho, W.M., Steinberg, J.L., Tam, J.S., Hui, P., Leung, N.W.Y., Zee, B. & Johnson, P.J. (2000) Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors. Journal of Medical Virology, 62, 299307.
  • Yeo, W., Zee, B., Zhong, S., Chan, P.K.S., Wong, W.L., Ho, W.M., Lam, K.C. & Johnson, P.J. (2004a) Comprehensive analysis of risk factors associating with hepatitis B virus (HBV) reactivation in cancer patients undergoing cytotoxic chemotherapy. British Journal of Cancer, 90, 13061311.
  • Yeo, W., Lam, K.C., Zee, B., Chan, P.S.K., Mo, F.K.F., Ho, W.M., Wong, W.L., Leung, T.W.T., Chan, A.T.C., Ma, B., Mok, T.S.K. & Johnson, P.J. (2004b) Hepatitis B reactivation in patients with hepatocellular carcinoma undergoing systemic chemotherapy. Annals of Oncology, 15, 16611666.
  • Yeo, W., Chan, P.K., Ho, W.M., Zee, B., Lam, K.C., Lpi, I.K., Chan, A.T.C., Mok, T.S.K., Lee, J.J., Leung, T.W.T., Zhong, S. & Johnson, P.J. (2004c) Lamivudine for the prevention of hepatitis B virus reactivation in Hepatitis B s-antigen seropositive cancer patients undergoing cytotoxic chemotherapy. Journal of Clinical Oncology, 22, 927934.
  • Yim, H.J. & Lok, A.S. (2006) Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005. Hepatology, 43 (2 Suppl. 1), 173181.
  • Yu, A.S., Cheung, R.C. & Keefe, E.B. (2006) Hepatitis B vaccines. Infectious Disease Clinics of North America, 20, 2745.
  • Zhong, S, Yeo W, Schroder, C, Chan, P.K., Wong, W.L., Ho, W.M., Mo, F, Zee, B & Johnson, P.J. (2004) High hepatitis B virus (HBV) DNA viral load is an important risk factor for HBV reactivation in breast cancer patients undergoing cytotoxic chemotherapy. Journal of Viral Hepatology, 11, 5559.